A recent study showed that a sublingual immunotherapy tablet for grass allergy, Grazax, has shown continued benefit for 2 years after the the therapy was stopped. Grazax, which contains grass allergen, has been available in Europe for the treatment of allergic rhinitis (hay fever), allergic conjunctivitis (eye allergies), and allergic asthma due to grass pollen. This is a form of sublingual (or under the tongue) immunotherapy, which actually changes the way a person’s body reacts to allergens. Immunotherapy is the only allergy therapy that can make a person less allergic and reduce or eliminate the need for allergy medications. The best part of immunotherapy is that the benefit continues for many years even after the immunotherapy is stopped.

Read more:

• Sublingual Immunotherapy
• Traditional Subcutaneous Immunotherapy (Allergy Shots)
• Grass Allergy